Replies to post #33203 on Lexaria Bioscience Corp (LEXX)

[billymayshear]

The three year adjusted high is $67.20 (US)...no reason it should not go to that level and beyond.

What is needed to get to that level, and beyond, is a big pharma company to join $LEXX in additional studies. Human studies can be done quickly with a number of currently safe therapeutics.

Hopefully Bunka has a number of big pharma boys on the phone today.

It would appear that the results of the current study was known a few days ago...see the volume spike with no news??

Bunka needs to move quickly to find one or more partners or this news will be like all other press releases in the past...one day wonders.